Eren OC, Mericoz CA, Bozkurtlar E, Bulutay P, et al. Novel ALK immunohistochemistry assay (clone OTI1A4, Dako) is a sensitive, reliable marker for identifying ALK rearrangements in lung adenocarcinomas: A validation study. Am J Clin Pathol 2024;161:71-82.
PMID: 37681660